Latest Articles

Publication Date
Applications open for the 2026 return of Ideas with Impact Awards - The National Tribune

Applications open for the 2026 return of Ideas with Impact Awards The National Tribune

Published: April 23, 2026, 12:02 p.m.
Endometriosis Drugs Sales Market Analysis By Application, - openPR.com

Endometriosis Drugs Sales Market Analysis By Application, openPR.com

Published: April 17, 2026, 11:10 a.m.
Biontech prepares FDA application after strong phase II results in endometrial cancer - medwatch.com

Biontech prepares FDA application after strong phase II results in endometrial cancer medwatch.com

Published: April 13, 2026, 12:14 p.m.
Applications open for Title X Family Planning Services Grants (US) - fundsforNGOs

Applications open for Title X Family Planning Services Grants (US) fundsforNGOs

Published: April 9, 2026, 7:38 a.m.
With a Record 70 Spots this Year, Team EndoStrong Has Opened Applications for the 2026 NYC Marathon - Endometriosis Foundation of America

With a Record 70 Spots this Year, Team EndoStrong Has Opened Applications for the 2026 NYC Marathon Endometriosis Foundation of America

Published: March 30, 2026, 7:45 p.m.
EndoCyclic New Drug application approved by US FDA for endometriosis treatment - Pharmafile

EndoCyclic New Drug application approved by US FDA for endometriosis treatment Pharmafile

Published: March 25, 2026, 10:58 a.m.
FDA clears ENDO-205 Investigational New Drug application for endometriosis - Contemporary OB/GYN

FDA clears ENDO-205 Investigational New Drug application for endometriosis Contemporary OB/GYN

Published: March 23, 2026, 7:30 p.m.
EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis - BioSpace

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis BioSpace

Published: March 23, 2026, 12:47 p.m.
EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis - PR Newswire

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis PR Newswire

Published: March 23, 2026, 11:30 a.m.
'Clear as mud' application process for endometriosis treatment putting women off, advocates say - Irish Examiner

'Clear as mud' application process for endometriosis treatment putting women off, advocates say Irish Examiner

Published: Jan. 19, 2026, 4 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!